Piperacillin-Tazobactam Dosing for Pneumonia in Older Adults
Part of Infections, Lungs & breathing clinical trials.
This study looks at the best way to give the antibiotic piperacillin-tazobactam (Zosyn) to people 65 and older who have pneumonia. It aims to make treatment more effective and safer for older adults.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 65 years old or older.
- You have been diagnosed with pneumonia.
- You are currently receiving the antibiotic piperacillin-tazobactam (Zosyn) through an IV.
- You are not allergic to penicillin or similar antibiotics.
- You do not need continuous dialysis (CRRT) and have no severe organ failure.
- You do not have an active cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how different types of sepsis affect treatment with the antibiotic piperacillin/tazobactam in patients with severe pneumonia. Researchers hope to find better ways to treat each person based on their specific condition.
This study looks at how the antibiotic Piperacillin/Tazobactam moves through the body of pregnant women and their newborns. It may help doctors decide the best dose to prevent infections in babies at risk.
This study looks at whether giving two antibiotics together is better for people hospitalized with severe pneumonia. It may help doctors choose the most effective treatment.
This study compares a new way of giving the antibiotic piperacillin/tazobactam: a shot under the skin every few hours instead of through an IV line. It is for hospital patients with severe infections who need this medicine continuously.
This study looks at how a common antibiotic is removed by kidney dialysis in very ill patients. This may help doctors give the right amount to keep the infection under control.
This study watches how safely two common antibiotics (vancomycin and a combination called piperacillin/tazobactam) work together in hospitalized patients with serious infections. Researchers want to make sure the combination doesn't harm kidney function.
Hear when a new Pneumonia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.